copy of P FACTOR ACTYVA HAIR LOSS AMPOULES VELIAN Complex

P FACTOR ACTYVA Hair Loss Ampoules VELIAN Complex

The ACTYVA specifications are based on three fundamental pillars: transparency, Green&Clean formulas, sustainability and safety for the environment and consumers.
CLEAR AND TRANSPARENT COMMUNICATION*

In order to promote clear and transparent communication, we have decided to make the packaging of our products " meaningful ", through the use of symbols that tell the characteristics of the line

https://kemoncertificazioni.cargo.site/pagina-fr-2021

Velian Complex A patented blend of plant extracts resulting from extensive scientific research conducted by Kemon in collaboration with Vivacell Biotechnology (Denzlingen, Germany) and the University of Ferrara.

The studies carried out have shown that "specific mixtures of extracts of Molene, Immortelle, Flax and Chamomile from dyers, from plants grown by Kemon [...], possess remarkable anti-inflammatory, antibacterial and anti-oxidant characteristics" and that the patented Velian Complex mixture produces an important synergistic effect, with results superior to those expected from each of the extracts separately.

KEY INGREDIENTS:

Grape grain stem cells
Saw Palmetto Extract
Hemp seed oil
Procyanidin from black grape seeds
Minerals and vitamins

PFACTOR Women Intensive

• PF Complex CS
• Formula, created to treat female hair loss in a targeted way
• Enriched with grape grain plant stem cells: Prevents and treats hair loss, protects bulb function, strengthens hair
• Guarantees perfect beauty and styling

Apply directly to the skin, drip, line by line.
Wring out with one finger after each application.
Spread over the entire scalp with circular movements.
Perform the massage as indicated in the P Factor Lotion gestural protocol.

Results of the efficacy test*: • more hair in 63% of cases • average increase in hair density +20.6% • improvement in the degree of alopecia in 52% of cases • well tolerated in 79% of cases • first visible results after three months * The test was carried out on a sample of 20 women, aged between 22 and 69 years, suffering from androgenetic alopecia to mild to severe degrees. The product was applied to volunteers for 6 months.